Cerus Corporation (CERS)
USD 1.21
(-6.2%)
USD 1.21
(-6.2%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 144.3 Million USD | -3.49% |
| 2022 | 149.53 Million USD | -1.55% |
| 2021 | 151.88 Million USD | 29.14% |
| 2020 | 117.6 Million USD | 8.41% |
| 2019 | 108.48 Million USD | 37.42% |
| 2018 | 78.94 Million USD | 33.11% |
| 2017 | 59.3 Million USD | 29.8% |
| 2016 | 45.68 Million USD | 2.2% |
| 2015 | 44.7 Million USD | 11.59% |
| 2014 | 40.06 Million USD | -1.29% |
| 2013 | 40.58 Million USD | 36.14% |
| 2012 | 29.81 Million USD | 10.19% |
| 2011 | 27.05 Million USD | 10.72% |
| 2010 | 24.43 Million USD | 87.34% |
| 2009 | 13.04 Million USD | -0.14% |
| 2008 | 13.06 Million USD | -28.71% |
| 2007 | 18.32 Million USD | 23.41% |
| 2006 | 14.84 Million USD | -36.51% |
| 2005 | 23.38 Million USD | -70.98% |
| 2004 | 80.58 Million USD | 22.22% |
| 2003 | 65.93 Million USD | 292.98% |
| 2002 | 16.77 Million USD | -21.98% |
| 2001 | 21.5 Million USD | 75.69% |
| 2000 | 12.24 Million USD | 39.09% |
| 1999 | 8.8 Million USD | -55.1% |
| 1998 | 19.6 Million USD | 308.33% |
| 1997 | 4.8 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 135.19 Million USD | -2.72% |
| 2024 Q3 | 135.25 Million USD | 0.05% |
| 2024 Q1 | 138.97 Million USD | -3.69% |
| 2023 Q4 | 144.3 Million USD | -7.98% |
| 2023 FY | 144.3 Million USD | -3.49% |
| 2023 Q1 | 149.77 Million USD | 0.16% |
| 2023 Q3 | 156.82 Million USD | 6.56% |
| 2023 Q2 | 147.17 Million USD | -1.74% |
| 2022 Q4 | 149.53 Million USD | 5.8% |
| 2022 FY | 149.53 Million USD | -1.55% |
| 2022 Q2 | 139.69 Million USD | -1.27% |
| 2022 Q1 | 141.49 Million USD | -6.84% |
| 2022 Q3 | 141.33 Million USD | 1.17% |
| 2021 Q2 | 138.98 Million USD | 8.63% |
| 2021 Q3 | 137.87 Million USD | -0.8% |
| 2021 Q4 | 151.88 Million USD | 10.16% |
| 2021 FY | 151.88 Million USD | 29.14% |
| 2021 Q1 | 127.94 Million USD | 8.79% |
| 2020 Q4 | 117.6 Million USD | 12.96% |
| 2020 Q2 | 100.96 Million USD | -1.93% |
| 2020 Q1 | 102.95 Million USD | -5.1% |
| 2020 FY | 117.6 Million USD | 8.41% |
| 2020 Q3 | 104.11 Million USD | 3.12% |
| 2019 Q4 | 108.48 Million USD | 4.68% |
| 2019 FY | 108.48 Million USD | 37.42% |
| 2019 Q1 | 106.42 Million USD | 34.82% |
| 2019 Q3 | 103.63 Million USD | -4.92% |
| 2019 Q2 | 108.99 Million USD | 2.41% |
| 2018 Q3 | 69.85 Million USD | 13.77% |
| 2018 Q2 | 61.4 Million USD | 4.38% |
| 2018 Q1 | 58.82 Million USD | -0.81% |
| 2018 FY | 78.94 Million USD | 33.11% |
| 2018 Q4 | 78.94 Million USD | 13.01% |
| 2017 Q1 | 43.45 Million USD | -4.89% |
| 2017 FY | 59.3 Million USD | 29.8% |
| 2017 Q4 | 59.3 Million USD | -1.0% |
| 2017 Q3 | 59.9 Million USD | 35.55% |
| 2017 Q2 | 44.19 Million USD | 1.7% |
| 2016 Q2 | 45.81 Million USD | 3.17% |
| 2016 FY | 45.68 Million USD | 2.2% |
| 2016 Q3 | 43.81 Million USD | -4.36% |
| 2016 Q4 | 45.68 Million USD | 4.28% |
| 2016 Q1 | 44.4 Million USD | -0.67% |
| 2015 Q1 | 33.28 Million USD | -16.91% |
| 2015 Q4 | 44.7 Million USD | 12.7% |
| 2015 Q3 | 39.66 Million USD | -2.96% |
| 2015 Q2 | 40.87 Million USD | 22.8% |
| 2015 FY | 44.7 Million USD | 11.59% |
| 2014 Q1 | 28.36 Million USD | -30.12% |
| 2014 Q4 | 40.06 Million USD | 24.73% |
| 2014 FY | 40.06 Million USD | -1.29% |
| 2014 Q2 | 32.64 Million USD | 15.11% |
| 2014 Q3 | 32.11 Million USD | -1.61% |
| 2013 Q3 | 43.79 Million USD | 58.65% |
| 2013 Q4 | 40.58 Million USD | -7.32% |
| 2013 FY | 40.58 Million USD | 36.14% |
| 2013 Q1 | 31.41 Million USD | 5.39% |
| 2013 Q2 | 27.6 Million USD | -12.15% |
| 2012 FY | 29.81 Million USD | 10.19% |
| 2012 Q4 | 29.81 Million USD | -6.07% |
| 2012 Q3 | 31.73 Million USD | 15.22% |
| 2012 Q2 | 27.54 Million USD | -15.8% |
| 2012 Q1 | 32.71 Million USD | 20.91% |
| 2011 Q3 | 20.38 Million USD | -21.16% |
| 2011 Q4 | 27.05 Million USD | 32.72% |
| 2011 Q2 | 25.85 Million USD | -2.66% |
| 2011 Q1 | 26.56 Million USD | 8.7% |
| 2011 FY | 27.05 Million USD | 10.72% |
| 2010 FY | 24.43 Million USD | 87.34% |
| 2010 Q3 | 19.85 Million USD | 11.44% |
| 2010 Q4 | 24.43 Million USD | 23.09% |
| 2010 Q2 | 17.81 Million USD | 14.86% |
| 2010 Q1 | 15.5 Million USD | 18.91% |
| 2009 FY | 13.04 Million USD | -0.14% |
| 2009 Q1 | 11.8 Million USD | -9.64% |
| 2009 Q3 | 17.2 Million USD | 32.67% |
| 2009 Q4 | 13.04 Million USD | -24.19% |
| 2009 Q2 | 12.96 Million USD | 9.88% |
| 2008 Q3 | 12.79 Million USD | -21.98% |
| 2008 FY | 13.06 Million USD | -28.71% |
| 2008 Q2 | 16.39 Million USD | 17.03% |
| 2008 Q4 | 13.06 Million USD | 2.09% |
| 2008 Q1 | 14.01 Million USD | -23.52% |
| 2007 FY | 18.32 Million USD | 23.41% |
| 2007 Q3 | 15.86 Million USD | 11.67% |
| 2007 Q4 | 18.32 Million USD | 15.47% |
| 2007 Q2 | 14.21 Million USD | 27.27% |
| 2007 Q1 | 11.16 Million USD | -24.79% |
| 2006 Q1 | 21.73 Million USD | -7.07% |
| 2006 Q2 | 17.26 Million USD | -20.58% |
| 2006 Q3 | 15.84 Million USD | -8.2% |
| 2006 Q4 | 14.84 Million USD | -6.3% |
| 2006 FY | 14.84 Million USD | -36.51% |
| 2005 Q4 | 23.38 Million USD | 29.67% |
| 2005 Q3 | 18.03 Million USD | -2.26% |
| 2005 FY | 23.38 Million USD | -70.98% |
| 2005 Q1 | 19.71 Million USD | -75.54% |
| 2005 Q2 | 18.45 Million USD | -6.4% |
| 2004 Q3 | 69.3 Million USD | -1.31% |
| 2004 Q4 | 80.58 Million USD | 16.28% |
| 2004 Q2 | 70.22 Million USD | 7.51% |
| 2004 Q1 | 65.32 Million USD | -0.93% |
| 2004 FY | 80.58 Million USD | 22.22% |
| 2003 FY | 65.93 Million USD | 292.98% |
| 2003 Q3 | 68.67 Million USD | 1.36% |
| 2003 Q4 | 65.93 Million USD | -3.99% |
| 2003 Q2 | 67.75 Million USD | 2.64% |
| 2003 Q1 | 66.01 Million USD | 293.43% |
| 2002 Q3 | 18.37 Million USD | -24.67% |
| 2002 Q4 | 16.77 Million USD | -8.7% |
| 2002 Q1 | 21.92 Million USD | 1.95% |
| 2002 FY | 16.77 Million USD | -21.98% |
| 2002 Q2 | 24.39 Million USD | 11.26% |
| 2001 Q2 | 19.98 Million USD | 12.21% |
| 2001 Q4 | 21.5 Million USD | -3.1% |
| 2001 FY | 21.5 Million USD | 75.69% |
| 2001 Q3 | 22.19 Million USD | 11.05% |
| 2001 Q1 | 17.81 Million USD | 45.51% |
| 2000 Q4 | 12.24 Million USD | -28.96% |
| 2000 FY | 12.24 Million USD | 39.09% |
| 2000 Q1 | 9.12 Million USD | 3.68% |
| 2000 Q2 | 15.54 Million USD | 70.42% |
| 2000 Q3 | 17.22 Million USD | 10.8% |
| 1999 Q2 | 13.8 Million USD | -31.34% |
| 1999 Q1 | 20.1 Million USD | 2.55% |
| 1999 Q3 | 9.4 Million USD | -31.88% |
| 1999 Q4 | 8.8 Million USD | -6.38% |
| 1999 FY | 8.8 Million USD | -55.1% |
| 1998 Q4 | 19.6 Million USD | 18.79% |
| 1998 FY | 19.6 Million USD | 308.33% |
| 1998 Q1 | 5.2 Million USD | 8.33% |
| 1998 Q3 | 16.5 Million USD | 18.71% |
| 1998 Q2 | 13.9 Million USD | 167.31% |
| 1997 Q4 | 4.8 Million USD | 33.33% |
| 1997 Q1 | 4.3 Million USD | 0.0% |
| 1997 FY | 4.8 Million USD | 0.0% |
| 1997 Q2 | 4.5 Million USD | 4.65% |
| 1997 Q3 | 3.6 Million USD | -20.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 51.25 Million USD | -181.547% |
| BrainsWay Ltd. | 15.31 Million USD | -842.301% |
| Envoy Medical, Inc. | 9.4 Million USD | -1434.822% |
| electroCore, Inc. | 8.94 Million USD | -1513.236% |
| Helius Medical Technologies, Inc. | 5.34 Million USD | -2601.31% |
| IceCure Medical Ltd | 4.24 Million USD | -3297.787% |
| Inogen, Inc. | 121.38 Million USD | -18.884% |
| OrthoPediatrics Corp. | 72.56 Million USD | -98.873% |
| Lucid Diagnostics Inc. | 29.58 Million USD | -387.827% |
| Monogram Orthopaedics, Inc. | 3.18 Million USD | -4435.091% |
| MaxCyte, Inc. | 36.1 Million USD | -299.657% |
| NeuroOne Medical Technologies Corporation | 1.84 Million USD | -7709.038% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -33831.448% |
| Orthofix Medical Inc. | 326.58 Million USD | 55.814% |
| PAVmed Inc | 57.13 Million USD | -152.558% |
| Rapid Micro Biosystems, Inc. | 25.46 Million USD | -466.72% |
| RxSight, Inc. | 22.18 Million USD | -550.37% |
| Sight Sciences, Inc. | 46.43 Million USD | -210.759% |
| SI-BONE, Inc. | 61.05 Million USD | -136.37% |
| TELA Bio, Inc. | 59.16 Million USD | -143.893% |
| Treace Medical Concepts, Inc. | 113.96 Million USD | -26.617% |
| Vivos Therapeutics, Inc. | 10.31 Million USD | -1298.43% |
| Acutus Medical, Inc. | 54.83 Million USD | -163.141% |
| Talis Biomedical Corporation | 29.22 Million USD | -393.786% |
| Spectral AI, Inc. | 12.4 Million USD | -1063.648% |
| Nano-X Imaging Ltd. | 23.13 Million USD | -523.775% |
| CVRx, Inc. | 39.28 Million USD | -267.354% |
| DIH Holding US, Inc. Warrants | 11.95 Million USD | -1106.749% |
| PetVivo Holdings, Inc. | 2.42 Million USD | -5840.147% |
| Bioventus Inc. | 589.79 Million USD | 75.533% |
| Venus Concept Inc. | 107.1 Million USD | -34.734% |
| TriSalus Life Sciences, Inc. | 51.66 Million USD | -179.318% |
| LivaNova PLC | 1.15 Billion USD | 87.473% |
| 908 Devices Inc. | 37.49 Million USD | -284.913% |
| Alphatec Holdings, Inc. | 703.48 Million USD | 79.487% |
| Nemaura Medical Inc. | 26.37 Million USD | -447.074% |
| NeuroPace, Inc. | 86.99 Million USD | -65.872% |
| LENSAR, Inc. | 22.4 Million USD | -543.956% |
| Apyx Medical Corporation | 52.31 Million USD | -175.821% |
| Cutera, Inc. | 518.12 Million USD | 72.149% |
| STRATA Skin Sciences, Inc. | 29.32 Million USD | -392.035% |
| BioSig Technologies, Inc. | 4.68 Million USD | -2980.128% |
| Anika Therapeutics, Inc. | 58.36 Million USD | -147.236% |
| ClearPoint Neuro, Inc. | 21.48 Million USD | -571.556% |
| Integra LifeSciences Holdings Corporation | 2.19 Billion USD | 93.423% |
| Axonics, Inc. | 82.35 Million USD | -75.213% |
| Outset Medical, Inc. | 190.91 Million USD | 24.415% |
| IRIDEX Corporation | 24.91 Million USD | -479.208% |
| PROCEPT BioRobotics Corporation | 123.96 Million USD | -16.407% |
| IRadimed Corporation | 20.73 Million USD | -595.913% |
| Tivic Health Systems, Inc. | 1.67 Million USD | -8520.311% |
| INVO Bioscience, Inc. | 19.99 Million USD | -621.702% |
| Telesis Bio, Inc. | 40.87 Million USD | -253.055% |
| Viemed Healthcare, Inc. | 40.79 Million USD | -253.771% |
| Varex Imaging Corporation | 668.6 Million USD | 78.417% |
| Quipt Home Medical Corp. | 136.29 Million USD | -5.878% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -3939.866% |
| Pulmonx Corporation | 60.63 Million USD | -137.984% |
| Dynatronics Corporation | 11.78 Million USD | -1124.98% |
| Modular Medical, Inc. | 2.27 Million USD | -6251.408% |
| ReShape Lifesciences Inc. | 4.06 Million USD | -3450.787% |
| Semler Scientific, Inc. | 6.27 Million USD | -2201.499% |
| InMode Ltd. | 75.91 Million USD | -90.089% |
| Bruker Corporation | 2.83 Billion USD | 94.913% |
| Cytosorbents Corporation | 29.98 Million USD | -381.246% |
| DexCom, Inc. | 4.19 Billion USD | 96.561% |
| Align Technology, Inc. | 2.45 Billion USD | 94.118% |
| Viveve Medical, Inc. | 10.84 Million USD | -1230.359% |
| ZimVie Inc. | 795.85 Million USD | 81.868% |
| Movano Inc. | 5.97 Million USD | -2316.343% |
| Cytek Biosciences, Inc. | 104.6 Million USD | -37.951% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -33831.448% |
| DIH Holdings US, Inc. Class A Common Stock | 11.95 Million USD | -1106.749% |
| Tandem Diabetes Care, Inc. | 639.02 Million USD | 77.418% |
| Profound Medical Corp. | 12.66 Million USD | -1039.314% |
| Insulet Corporation | 1.85 Billion USD | 92.223% |
| enVVeno Medical Corporation | 2.43 Million USD | -5826.242% |
| Surmodics, Inc. | 65.82 Million USD | -119.23% |
| iCAD, Inc. | 8 Million USD | -1703.575% |
| Nuwellis, Inc. | 6.78 Million USD | -2028.378% |
| Biotricity, Inc. | 35.91 Million USD | -301.743% |
| iRhythm Technologies, Inc. | 223.04 Million USD | 35.303% |
| Aethlon Medical, Inc. | 2.47 Million USD | -5719.531% |
| InspireMD, Inc. | 8.14 Million USD | -1672.341% |
| PAVmed Inc. | 57.13 Million USD | -152.558% |
| BIOLASE, Inc. | 35.34 Million USD | -308.238% |
| Beyond Air, Inc. | 29.77 Million USD | -384.648% |
| FONAR Corporation | 57.45 Million USD | -151.149% |
| AxoGen, Inc. | 101.16 Million USD | -42.646% |
| Vivani Medical, Inc. | 25.03 Million USD | -476.386% |
| Tactile Systems Technology, Inc. | 87.79 Million USD | -64.363% |
| Inari Medical, Inc. | 209.32 Million USD | 31.062% |
| UFP Technologies, Inc. | 118.04 Million USD | -22.245% |
| QT Imaging Holdings, Inc. | 12.69 Million USD | -1037.103% |
| Heart Test Laboratories, Inc. | 2.18 Million USD | -6501.849% |
| Tenon Medical, Inc. | 5.56 Million USD | -2492.132% |
| Autonomix Medical, Inc. Common Stock | 1.77 Million USD | -8011.523% |
| Co-Diagnostics, Inc. | 17.63 Million USD | -718.323% |
| AdaptHealth Corp. | 3.15 Billion USD | 95.424% |
| Sintx Technologies, Inc. | 6.59 Million USD | -2088.746% |
| NanoVibronix, Inc. | 2.68 Million USD | -5272.45% |
| Quanterix Corporation | 78.08 Million USD | -84.806% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -3939.866% |
| Sensus Healthcare, Inc. | 4.88 Million USD | -2854.023% |
| Pacific Biosciences of California, Inc. | 1.04 Billion USD | 86.187% |
| TransMedics Group, Inc. | 568.84 Million USD | 74.632% |
| ReWalk Robotics Ltd. | 16.68 Million USD | -765.028% |
| NeuroMetrix, Inc. | 1.33 Million USD | -10724.499% |
| Hyperfine, Inc. | 9.8 Million USD | -1372.49% |
| Establishment Labs Holdings Inc. | 250.24 Million USD | 42.335% |
| Biomerica, Inc. | 2.66 Million USD | -5318.851% |
| Bone Biologics Corporation | 831.4 Thousand USD | -17256.706% |
| AVITA Medical, Inc. | 19.86 Million USD | -626.409% |
| Bluejay Diagnostics, Inc. | 1.97 Million USD | -7211.407% |
| Silk Road Medical, Inc | 114.15 Million USD | -26.407% |